ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,451 | +243.0% | 128,440 | +355.4% | 0.04% | +387.5% |
| Q2 2023 | $1,006 | +393.1% | 28,206 | +250.5% | 0.01% | +300.0% |
| Q1 2023 | $204 | -79.6% | 8,048 | -67.4% | 0.00% | -83.3% |
| Q4 2022 | $1,000 | -99.9% | 24,654 | -41.0% | 0.01% | -29.4% |
| Q3 2022 | $1,382,000 | -66.7% | 41,818 | -64.6% | 0.02% | -61.4% |
| Q2 2022 | $4,155,000 | -11.7% | 118,014 | +15.4% | 0.04% | +25.7% |
| Q1 2022 | $4,704,000 | -45.6% | 102,293 | -21.6% | 0.04% | -25.5% |
| Q4 2021 | $8,646,000 | +11.2% | 130,401 | +4.7% | 0.05% | +27.0% |
| Q3 2021 | $7,775,000 | -17.6% | 124,537 | +9.3% | 0.04% | -15.9% |
| Q2 2021 | $9,435,000 | +158.6% | 113,923 | +107.0% | 0.04% | +131.6% |
| Q1 2021 | $3,649,000 | +22.5% | 55,033 | +41.7% | 0.02% | +18.8% |
| Q4 2020 | $2,979,000 | +43.5% | 38,829 | -19.5% | 0.02% | +23.1% |
| Q3 2020 | $2,076,000 | +14.7% | 48,223 | +15.1% | 0.01% | -13.3% |
| Q2 2020 | $1,810,000 | +46.7% | 41,904 | -2.3% | 0.02% | +25.0% |
| Q1 2020 | $1,234,000 | -6.3% | 42,883 | +106.5% | 0.01% | 0.0% |
| Q4 2019 | $1,317,000 | -43.7% | 20,766 | -75.0% | 0.01% | -36.8% |
| Q3 2019 | $2,339,000 | +260.4% | 83,005 | +239.1% | 0.02% | +375.0% |
| Q2 2019 | $649,000 | +524.0% | 24,478 | +330.3% | 0.00% | +300.0% |
| Q1 2019 | $104,000 | -37.3% | 5,688 | -57.4% | 0.00% | 0.0% |
| Q4 2018 | $166,000 | +253.2% | 13,350 | +21.9% | 0.00% | – |
| Q3 2017 | $47,000 | +161.1% | 10,952 | +1.3% | 0.00% | – |
| Q2 2017 | $18,000 | -90.3% | 10,811 | -89.3% | 0.00% | -100.0% |
| Q1 2017 | $186,000 | +365.0% | 100,747 | +287.9% | 0.00% | – |
| Q4 2016 | $40,000 | -48.7% | 25,971 | +144.9% | 0.00% | -100.0% |
| Q3 2016 | $78,000 | – | 10,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |